Streetbeat News

Products Services

FDMT

4D Molecular Therapeutics announced positive interim clinical data from its 4D-710 Phase 1/2 AEROW clinical trial for the treatment of cystic fibrosis lung disease, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 8:40 pm

LAKE

Lakeland Industries President and CEO Charlie Roberson announced that the company's fire and other key high-value product lines are performing positively, and they are maintaining their targeted level of profitability in terms of gross profit and adjusted EBITDA margin.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 8:38 pm

AAPL

CMCSA

Apple Inc has acquired augmented reality headset company Mira, which has worked on Mario Kart rides at Nintendo World theme parks. The acquisition comes after Apple unveiled its mixed-reality headset, Apple Vision Pro, at the Worldwide Developer Conference.

Portfolio Pulse from Chris Katje

June 07, 2023 | 8:34 pm

SVRE

SaverOne 2014 Ltd. (NASDAQ:SVRE) announced the successful installation of its Driver Distraction Prevention Solution (DDPS) on over 160 buses for six private bus fleet customers. The DDPS system helps reduce driver distraction and improve road safety.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 8:33 pm

ALLO

Allogene Therapeutics is enrolling patients for its potentially pivotal Phase 2 Alpha2 trial of ALLO-501A in large B-cell lymphoma, with enrollment expected to be completed in H1 2024, according to an SEC filing.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 8:27 pm

APT

JETS

MMM

New York City experienced the worst air quality in the world on Wednesday due to Canadian wildfires, leading to outdoor activities being canceled and flights delayed. Companies producing masks, such as 3M Co and Alpha Pro Tech, could benefit if the situation persists.

Portfolio Pulse from Aaron Bry

June 07, 2023 | 8:13 pm

FDMT

4D Molecular Therapeutics (NASDAQ:FDMT) announced positive interim data from the 4D-710 Phase 1/2 AEROW clinical trial for the treatment of cystic fibrosis lung disease. The trial showed meaningful improvement in cystic fibrosis-related quality of life and improved or stabilized ppFEV1. The company plans to initiate the Phase 2 Dose Expansion stage in H2 2023.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 8:11 pm

RPTX

Repare Therapeutics reports initial proof of concept monotherapy data from its Phase 1 MYTHIC clinical trial evaluating lunresertib, a first-in-class oral PKMYT1 inhibitor in molecularly selected advanced solid tumors. The data show a favorable tolerability profile and preliminary antitumor activity, supporting the development plans for the lunresertib program.

Portfolio Pulse from Happy Mohamed

June 07, 2023 | 8:08 pm

ATVI

Activision Blizzard's 'Diablo 4' has become the fastest-selling game in the company's history, with 93 million hours of playtime since its early access launch on June 1. However, the game's expensive in-game shop and microtransactions have sparked controversy among fans.

Portfolio Pulse from Franca Quarneti

June 07, 2023 | 7:56 pm

STLA

TSLA

VWAGY

WKSPW

Panasonic and Tesla are increasing battery factory production, while Tesla's Cybertruck is set to be delivered by Q3 2021. Worksport improved its COR portable energy system, Volkswagen announced the all-electric ID.Buzz, and Stellantis is investing €160 million in EV production.

Portfolio Pulse from Upwallstreet

June 07, 2023 | 7:55 pm